[Therapeutic approach to the nephrotic syndrome in children].
Barras
M H
MH
Service de pédiatrie, CHUV, Lausanne.
Guignard
J P
JP
D000293:Adolescent; D000477:Alkylating Agents / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007223:Infant; D007978:Levamisole / Q000627:therapeutic use; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence
D000477:Alkylating Agents; D000806:Angiotensin-Converting Enzyme Inhibitors; D007978:Levamisole; D016572:Cyclosporine; D011241:Prednisone
Approche thérapeutique du syndrome néphrotique chez l'enfant.